VSTM SEC Filings, Earnings & Splits

Verastem, Inc. filed a preliminary prospectus supplement for an underwritten public offering of common stock and pre-funded warrants, with the last reported sale price of its common stock at $7.45 per share on October 13, 2026.

Verastem, Inc. priced an underwritten public offering of 30,937,500 shares of common stock at $8.00 per share, plus pre-funded warrants to purchase up to 312,503 shares, for total gross proceeds of approximately $250 million. Net proceeds to the company are expected to be approximately $235 million before expenses.

Verastem, Inc. filed a Form 8-K cover page with the SEC on October 14, 2026, reporting an event date of October 12, 2026. The filing contains only cover page XBRL metadata with no substantive disclosure of a specific corporate event.

Verastem, Inc. filed a Form 8-K cover page dated October 14, 2026. The filing contains only XBRL cover page data with no substantive event disclosure.

Verastem, Inc. filed an 8-K form with the SEC on August 6, 2026, providing standard corporate information and confirming no material events occurred requiring disclosure under Items 1-7 of Form 8-K.

Verastem, Inc. filed a Form 8-K with the SEC on August 6, 2026, providing standard cover page information and confirming no material events were reported.

Verastem, Inc. filed its quarterly report (10-Q) for the period ended June 30, 2026, reporting financial results and business updates.